Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.

Leukemia (AML)

Acute Myeloid Leukemia (Credit: National Cancer Institute)

Kurtz SE, Eide CA, Kaempf A, Mori M, Tognon CE, Borate U, Druker BJ, Tyner JW.

Leukemia

September 01, 2018
Program:
CTD²
Last updated: June 28, 2020